London Hospital Anticipates the Future of Video Laryngoscopy

Printer-friendly versionPrinter-friendly version

University College Hospital London (UCHL) has recently purchased 19 Verathon, Inc. GlideScope® systems in response to guidelines from the Difficult Airways Society recommending much greater accessibility to video laryngoscopy in hospitals.


City, State, United Kingdom., December 4, 2017 - (PressReleasePoint) -


University College Hospital London (UCHL) has recently purchased 19 Verathon, Inc. GlideScope® systems in response to guidelines from the Difficult Airways Society recommending much greater accessibility to video laryngoscopy in hospitals. The supply contract was awarded to the medical device company Verathon, and its intubation technology is now widely available across UCHL’s 26 operating theatres.

 

Dr Simon Clarke, a consultant anaesthetist, explained: “Around 30 per cent of our patients need intubation, and we have a comparatively large proportion of people coming through with difficult airways, as we are a tertiary referral centre for head and neck cancer. We have over 10 years’ experience working with Verathon’s GlideScope, and the choice of four reusable blades designed for normal and difficult airways offers the versatility we need, as well as cutting down on our waste.”

 

Dr James Holding, a fellow anaesthetist, continued: “We are very impressed with the device. It’s straightforward to disinfect between different patients, and it ticks all the boxes; it is hard wearing, easy to set up and simple to use, making it a fantastic training tool. We train over 100 anaesthetists every year, and the video capability lets me see the same view as a junior doctor so that I can offer guidance during procedures, and recommend the right amount of pressure on the neck to alter the view of the larynx and the glottis. We anticipate that within a few years it will be standard practice to intubate every patient, and we’ll wonder how we ever managed without video laryngoscopy.”

 

About Verathon

Verathon is a global medical device company focused on supporting customers by being their trusted partner, delivering high-quality products that endure over time and ensure clinical and economic utility.  Two areas where Verathon has significantly impacted patient care, and become the market leader in each, are bladder volume measurement and airway management.  The company’s BladderScan portable ultrasound and GlideScope video laryngoscopy systems effectively address unmet needs for healthcare providers and meaningfully raise the standard of care for patients.  Verathon, a subsidiary of Roper Technologies, is headquartered in Bothell, Washington, and has international subsidiaries in Canada, Europe and Asia.  For more information, please visit verathon.com.

 

About Roper Technologies

Roper Technologies is a constituent of the S&P 500, Fortune 1000, and the Russell 1000 indices. Roper designs and develops software (both software-as-a-service and licensed), and engineered products and solutions for healthcare, transportation, food, energy, water, education and other niche markets worldwide.  Additional information about Roper is available on the Company’s website at www.ropertech.com

 

BladderScan, the BladderScan symbol, GlideScope, the GlideScope symbol, Verathon, and the Verathon Torch symbol are registered trademarks of Verathon Inc. © 2017.


Press Contact:
kdm communications
Yew Tree House, Ground Floor
10 Church Street
01480405333
*****@**m**o**u**c**i**s.com
Email partially hidden to block spam. Please use the contact form here.
Contact kdm communications
Email the contact person for this press release. Do not send spam or irrelevant message.
4 + 14 =


Copy this html code to your website/blog to embed this press release.

Comments

Post new comment

1 + 1 =

To prevent automated spam submissions leave this field empty.